Clinical Trial Update: Doxorubicin and Cisplatin With or Without Paclitaxel in Treating Patients With Locally Advanced, Metastatic, and/or Relapsed Endometrial Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating doxorubicin and cisplatin with or without paclitaxel in locally advanced, metastatic, and/or relapsed endometrial cancer. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Doxorubicin (doxorubicin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Endometrial Cancer | Phase 2 | Status: COMPLETED